Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
| Class:Id | LiteratureReference:9736030 |
|---|---|
| _displayName | Synergistic activities of MET/RON inhibitor BMS-777607 and mTOR inhibitor AZD8055 to polyploid cells derived from pancreatic cancer and cancer stem cells |
| _timestamp | 2021-07-06 12:53:06 |
| author | [Person:9736167] Zeng, Jun-Ying [Person:9736112] Sharma, Sharad [Person:9736174] Zhou, Yong-Qing [Person:9736041] Yao, Hang-Ping [Person:9736120] Hu, Xing [Person:9736267] Zhang, Ruiwen [Person:9736125] Wang, Ming-Hai |
| created | [InstanceEdit:9736264] Orlic-Milacic, Marija, 2021-07-06 |
| journal | Mol Cancer Ther |
| pages | 37-48 |
| pubMedIdentifier | 24233399 |
| title | Synergistic activities of MET/RON inhibitor BMS-777607 and mTOR inhibitor AZD8055 to polyploid cells derived from pancreatic cancer and cancer stem cells |
| volume | 13 |
| year | 2014 |
| (literatureReference) | [Reaction:9735946] Anti-MET small tyrosine kinase inhibitors bind MET [Homo sapiens] |
| [Change default viewing format] | |